New Delhi: Bharat Biotech’s Covaxin approved for kids aged 2-18 yrs by Subject Expert Committee. Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN (BBV152) to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and has provided their positive recommendations.
Comments are closed.